Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 Profit Margin

Harrow- 8.625% NT REDEEM 30/04/2026 USD 25's profit margin stands at -5.57% as of March 2026. That compares with -10.19% in the prior-year period — up 45.4% year over year. That is below the Healthcare sector average of 14.34%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 reported -5.57% in profit margin versus -10.19% a year earlier — a 45.4% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 sits lower the Healthcare benchmark (14.34%) with a profit margin of -5.57%. That is roughly 138.8% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -5.57% for Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Harrow- 8.625% NT REDEEM 30/04/2026 USD 25's profit margin evolved across reporting periods, while the comparison chart places HROWL next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.